Head of Investor Relations Welcome to the Q4 and full year 2024 conference call for investors and analysts. As usual, you can find the slides on sanofi.com. Please turn to Slide 3. Here we have the ...

Verona Pharma has claimed FDA approval for its chronic obstructive pulmonary disease (COPD) drug ensifentrine ... given the somewhat tongue-twisting brand name of Ohtuvayre – is the first ...

Welcome to the Q2 fiscal-year 2025 ResMed earnings conference call. My name is Matt and I'll be your operator for today's call. (Operator Instructions) Please note that this conference call is being ...

Q2 2025 Earnings Call Transcript January 30, 2025 ResMed Inc. beats earnings expectations. Reported EPS is $2.43, expectations were $2.32. Operator: Welcome to the Q2 Fiscal Year 2025 ResMed Earnings ...

India's pharmaceutical industry is set for growth, driven by strong market players, global reputation, and evolving trends.

COPD treatment goal is to help you breathe easier and help regular activities. Medications along with lifestyle approaches can help. When you have COPD, medications can go a long way to help you ...

There was evidence that patients on the drug improved their health compared to those on standard care, as measured by the COPD Assessment Test (CAT) but, overall, the full data is less than ...

The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...

A non-opioid pain medication made by Vertex Pharmaceuticals has received approval for adults from the Food and Drug ...

People with COPD experience more falls and related injuries requiring medical care when using common fall-risk increasing drugs, according to a new study. The study is published in the November 2024 ...

Since Viagra is a brand-name medication, the price of Viagra is very high and may not currently fit within your budget. But a generic version (and the active ingredient) of this popular medication ...